SEARCH

SEARCH BY CITATION

References

  • 1
    . Dayer J-M, Demczuk S: Cytokines and other mediators in rheumatoid arthritis. Springer Semin Immunopathol 7: 387413, 1984
  • 2
    . Zvaifler NJ: New perspectives on the pathogenesis of rheumatoid arthritis. Am J Med 85A: 1217, 1988
  • 3
    . Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M: Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet II: 244247 1989
  • 4
    . Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: Cytokines in chronic inflammatory arthritis. IV. Granulocyte/ macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis. J Exp Med 170: 865875, 1989
  • 5
    . Dinarello CA: Interleukin-1 and its biologically related cytokines. Adv Immunol 44: 153205, 1989
  • 6
    . Miossec P: The role of interleukin 1 in the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 5: 305308, 1987
  • 7
    . Dayer J-M, De Rochemonteix B, Burrus B, Demczuk S, Dinarello CA: Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 77: 645648, 1986
  • 8
    . Evěquoz V, Bettens F, Kristensen F, Trechsel U, Stadler BM, Dayer J-M, De Weck AL, Fleisch H: Interleukin 2-independent stimulation of rabbit chondrocyte collagenase and prostaglandin E2 production by an interleukin 1-like factor. Eur J Immunol 14: 490495, 1984
  • 9
    . Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH: Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1α and β. J Cell Biol 106: 311318, 1988
  • 10
    . Raines EW, Dower SK, Ross R: Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243: 393396, 1989
  • 11
    . Krane SM, Dayer J-M, Simon LE, Byrne MS: Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin. Coll Relat Res 5: 99117, 1985
  • 12
    . Yaron I, Meyer FA, Dayer J-M, Bleiberg I, Yaron M: Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum 32: 173180, 1989
  • 13
    . Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM: Interleukin 1 suppresses expression of cartilagespecific types II and IX collagens and increases type I and III collagens in human chondrocytes. J Clin Invest 82: 20262037, 1988
  • 14
    . Dayer J-M, Trentham DE, Krane SM: Collagens act as ligands to stimulate human monocytes to produce mononuclear cell factor (MCF) and prostaglandins (PGE2). Coll Relat Res 2: 523540, 1982
  • 15
    . Dayer J-M, Ricard-Blum S, Kaufmann M-T, Herbage D: Type IX collagen is a potent inducer of PGE2 and interleukin 1 production by human monocyte macrophages. FEBS Lett 198: 208212, 1986
  • 16
    . Arner EC, Pratta MA: Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum 32: 288297, 1989
  • 17
    . Pettipher ER, Higgs GA, Henderson B: Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 83: 87498753, 1986
  • 18
    . Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH: Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol 140: 29642969, 1988
  • 19
    . Hom JT, Bendele AM, Carlson DG: In vivo administration with IL-1 accelerates the development of collageninduced arthritis in mice. J Immunol 141: 834841, 1988
  • 20
    . Jacobs C, Young D, Tyler S, Callis G, Gillis S, Conlon PJ: In vivo treatment with IL-1 reduces the severity and duration of antigen-induced arthritis in rats. J Immunol 141: 29672974, 1988
  • 21
    . Wallach D, Holtmann H, Engelmann H, Nophar Y: Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. J Immunol 140: 29942999, 1988
  • 22
    . Henderson B, Rowe FM, Bird CR, Gearing AJH: Production of interleukin 1 in the joint during the development of antigen-induced arthritis in the rabbit. Clin Exp Immunol 74: 371376, 1988
  • 23
    . Hopkins SJ, Humphreys M, Jayson MIV: Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 72: 422427, 1988
  • 24
    . Yamagata N, Kobayashi K, Kasama T, Fukushima T, Tabata M, Yoneya I, Shikama Y, Kaga S, Hashimoto M, Yoshida K, Sekine F, Negishi M, Ide H, Mori Y, Takahashi T: Multiple cytokine activities and loss of interleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis. J Rheumatol 15: 16231627, 1988
  • 25
    . Bhardwaj N, Lau LL, Rivelis M, Steinman RM: Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions. Cell Immunol 114: 405423, 1988
  • 26
    . Miyasaka N, Sato K, Goto M, Sasano M, Natsuyama M, Inoue K, Nishioka K: Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum 31: 480486, 1988
  • 27
    . Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M: Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 73: 449455, 1988
  • 28
    . Firestein GS, Alvaro-Gracia JM, Zvaifler NJ: Quantitative analysis of cytokine gene expression in rheumatoid arthritis (abstract). Clin Res 37: 586A, 1989
  • 29
    . Eastgate JA, Symons JA, Wood NC, Grinlinton FM, Di Giovine FS, Duff GW: Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet II: 706709, 1988
  • 30
    . Shore A, Jaglal S, Keystone EC: Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 65: 293302, 1986
  • 31
    . Dayer J-M, Seckinger P: Natural inhibitors and antagonists of interleukin 1, Interleukin 1, Inflammation and Disease. Edited by RHR.Bomford, B.Henderson. Amsterdam, Elsevier, 1989
  • 32
    . Arend WP, Joslin FG, Thompson RC, Hannum CH: An interleukin 1 inhibitor from human monocytes: production and characterization of biological properties. J Immunol 143: 18511858, 1989
  • 33
    . Larrick JW: Native interleukin 1 inhibitors. Immunol Today 10: 6166, 1989
  • 34
    . Arend WP, Joslin FG, Massoni RJ: Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol 134: 38683875, 1985
  • 35
    . Balavoine J-F, De Rochemonteix B, Williamson K, Seckinger P, Cruchaud A, Dayer J-M: Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest 78: 11201124, 1986
  • 36
    . Seckinger P, Williamson K, Balavoine J-F, Mach B, Mazzei G, Shaw A, Dayer J-M: A urine inhibitor of interleukin 1 activity affects both interleukin 1α and 1β but not tumor necrosis factor α. J Immunol 139: 15411545, 1987
  • 37
    . Seckinger P, Lowenthal JW, Williamson K, Dayer J-M, MacDonald HR: A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 139: 15461549, 1987
  • 38
    . Roux-Lombard P, Modoux C, Dayer J-M: Production of interleukin 1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF. Cytokine 1: 4551, 1989
  • 39
    . Lotz M, Carson DA: Transforming growth factor β and cellular immune responses in synovial fluids (abstract). Arthritis Rheum 32 (suppl 4): S42, 1989
  • 40
    . Lotz M, Tsoukas CD, Robinson CA, Dinarello CA, Carson DA, Vaughan JH: Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies. J Clin Invest 78: 713721, 1986
  • 41
    . Roux-Lombard P, Modoux C, Dayer J-M: Inhibitors of IL-1 and TNFα activities in synovial fluids and cultured synovial fluid cell supernatants (abstract). Calcif Tissue Int 42: S(A47), 1988
  • 42
    . Prieur A-M, Kaufmann M-T, Griscelli C, Dayer J-M: Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 11: 12401242, 1987
  • 43
    . Sherry B, Cerami A: Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 107: 12691277, 1988
  • 44
    . Dayer J-M, Beutler B, Cerami A: Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162: 21632168, 1985
  • 45
    . Henderson B, Pettipher ER: Arthritogenic actions of recombinant IL-1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between eytokines in vivo. Clin Exp Immunol 75: 306310, 1989
  • 46
    . Yocum DE, Esparza L, Dubry S, Benjamin JB, Volz R, Scuderi P: Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol 122: 131145, 1989
  • 47
    . Hopkins SJ, Meager A: Cytokines in synovial fluid. II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 73: 8892, 1988
  • 48
    . Saxne T, Palladino MA Jr, Heinegàrd D, Talal N, Wollheim FA: Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31: 10411045, 1988
  • 49
    . Husby G, Williams RC Jr: Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1: 363371, 1988
  • 50
    . Seckinger P, Isaaz S, Dayer J-M: A human inhibitor of tumor necrosis factor α. J Exp Med 167: 15111516, 1988
  • 51
    . Seckinger P, Isaaz S, Dayer J-M: Purification and biologic characterization of a specific tumor necrosis factor α inhibitor. J Biol Chem 264: 1196611973, 1989
  • 52
    . Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D: A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264: 1197411980, 1989
  • 53
    . Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G: Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 42: 270275, 1989
  • 54
    . Novick D, Engelmann H, Wallach D, Rubenstein M: Soluble cytokine receptors are present in normal urine. J Exp Med 170: 14091414, 1989
  • 55
    . Wong GG, Clark SC: Multiple actions of interleukin 6 within a cytokine network. Immunol Today 9: 137139, 1988
  • 56
    . Guerne P-A, Zuraw BL, Vaughan JH, Carson DA, Lotz M: Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 83: 585592, 1989
  • 57
    . Houssiau FA, Devogelaer J-P, Van Damme J, Nagant de Deuxchaisnes C, Van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31: 784788, 1988
  • 58
    . Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, Kishimoto T: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 17971801, 1988
  • 59
    . Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivelis M, Steinman RM, Sehgal PB, May LT: IL-6/IFN-β2 in synovial effusions of patients with rheumatoid arthritis and other arthritides: identification of several isoforms and studies of cellular sources. J Immunol 143: 21532159, 1989
  • 60
    . Miyasaka N, Sato K, Hashimoto J, Kohsaka H, Yamamoto K, Goto M, Inoue K, Matsuda T, Hirano T, Kishimoto T, Nishioka K: Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clin Immunol Immunopathol 52: 238247, 1989
  • 61
    . Burmester GR, Jahn B, Rohwer P, Zacher J, Winchester RJ, Kalden JR: Differential expression of Ia antigens by rheumatoid synovial lining cells. J Clin Invest 80: 595604, 1987
  • 62
    . Firestein GS, Zvaifler NJ: Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor. Arthritis Rheum 30: 864871, 1987
  • 63
    . Firestein GS, Xu W-D, Townsend K, Broide D, Alvaro-Gracia J, Glasebrook A, Zvaifler NJ: Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 168: 15731586, 1988
  • 64
    . Xu W-D, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ: Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 83: 876882, 1989
  • 65
    . Williamson DJ, Begley CG, Vadas MA, Metcalf D: The detection and initial characterization of colonystimulating factors in synovial fluid. Clin Exp Immunol 72: 6773, 1988
  • 66
    . Hamerman D, Taylor S, Kirschenbaum I, Klagsbrun M, Raines EW, Ross R, Thomas KA: Growth factors with heparin binding affinity in human synovial fluid. Proc Soc Exp Biol Med 186: 384389, 1987
  • 67
    . Lafyatis R, Thompson N, Remmers E, Flanders K, Roberts A, Sporn M, Wilder RL: Demonstration of local production of PDGF and TGF-β by synovial tissue from patients with rheumatoid arthritis (abstract). Arthritis Rheum 31 (suppl 4): S62, 1988
  • 68
    . Butler DM, Leizer T, Hamilton JA: Stimulation of human synovial fibroblast DNA synthesis by plateletderived growth factor and fibroblast growth factor. J Immunol 142: 30983103, 1989
  • 69
    . Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL: Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 83: 12671276, 1989
  • 70
    . Kumkumian GK, Lafyatis R, Remmers EF, Case JP, Kim S-J, Wilder RL: Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis: regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription. J Immunol 143: 833837, 1989
  • 71
    . Sporn MB, Roberts AB, Wakefield LM, De Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105: 10391045, 1987
  • 72
    . Czarniecki CW, Chiu HH, Wong GHW, McCabe SM, Palladino MA: Transforming growth factor-β modulates the expression of class II histocompatibility antigens on human cells. J Immunol 140: 42174223, 1988
  • 73
    . Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T: Active and latent forms of transforming growth factor β activity in synovial effusions. J Exp Med 169: 291296, 1989
  • 74
    . Lafyatis R, Thompson NL, Remmers EF, Flanders KC, Roche NS, Kim S-J, Case JP, Sporn MB, Roberts AB, Wilder RL: Transforming growth factor-β production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats: studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol 143: 11421148, 1989
  • 75
    . Wahl SM, Hunt DA, Bansal G, McCartney-Francis N, Ellingsworth L, Allen JB: Bacterial cell wall-induced immunosuppression: role of transforming growth factor β. J Exp Med 168: 14031417, 1988